NASDAQ:CRBU

Caribou Biosciences Stock Forecast

etoro logo Buy CRBU
*Your capital is at risk
$1.46
-0.0500 (-3.31%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of CRBU AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRBU to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Caribou Biosciences, Inc. stock after losing 3.31%
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Loss -24.16%

The Caribou Biosciences, Inc. stock price fell by -3.31% on the last day (Friday, 31st Jul 2026) from $1.51 to $1.46. During the last trading day the stock fluctuated 6.99% from a day low at $1.43 to a day high of $1.53. The price has fallen in 6 of the last 10 days and is down by -11.52% for this period. Volume has increased on the last day by 212 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $1.65 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.34 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.68% during the next 3 months and, with a 90% probability hold a price between $1.05 and $1.60 at the end of this 3-month period.

CRBU Signals & Forecast

There are few to no technical positive signals at the moment. The Caribou Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.53 and $1.69. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -24.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Caribou Biosciences, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 6.99%. For the last week, the stock has had daily average volatility of 6.06%.

Caribou Biosciences, Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRBU) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Caribou Biosciences, Inc. to open at $1.47, and during the day (based on 14 day Average True Range), to move between $1.41 and $1.51, which gives a possible trading interval of +/-$0.105 (+/-7.47%) up or down from last closing price. If Caribou Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 7.47% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.64, some $0.180 (12.33%) from the current price of $1.46, our system finds the risk reward not very attractive.

Is Caribou Biosciences, Inc. stock A Buy?

Caribou Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.877 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $1.47 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRBU Performance

Trading levels for CRBU

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.57 7.76%
R2 1.54 5.15%
R1 1.51 3.53%
Price 1.46
S1 1.44 -1.70%
S2 1.41 -3.32%
S3 1.37 -5.94%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.68 15.07%
R2 1.66 13.70%
R1 1.64 12.33%
Price 1.46
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Caribou Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Caribou Biosciences, Inc. is CRBU and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Caribou Biosciences, Inc. Stock?
Caribou Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Caribou Biosciences, Inc. Stock?
Caribou Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Caribou Biosciences, Inc. Stock.

What's the current price of Caribou Biosciences, Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Caribou Biosciences, Inc. (CRBU) share was $1.46.

What is the 52-week high and low for Caribou Biosciences, Inc. Stock?
The 52-week high for Caribou Biosciences, Inc. Stock is $3.53 and the 52-week low is $1.38.

What is the market capitalization of Caribou Biosciences, Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Caribou Biosciences, Inc. is 144.804M.

When is the next earnings date for Caribou Biosciences, Inc.?
The upcoming earnings date for Caribou Biosciences, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT CARIBOU BIOSCIENCES, INC.
Caribou Biosciences
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE